BIOTRONIK Dynetic-35 Stent for the Treatment of Peripheral Iliac Lesions

To be part of this study, you had to be at least 18 years old and able to understand and sign the consent forms yourself. The study was for people who had blocked or narrowed blood vessels in their pelvis (iliac arteries) due to fatty deposits. The doctors checked that the narrowed section was of a certain size (between 5mm and 10mm wide and up to 100mm long) and that it was severely narrowed (more than 70% blocked).

You also needed to be experiencing symptoms like leg pain when walking, which doctors classify based on how severe it is. Importantly, you would need to have other healthy blood vessels nearby. The study included both newly developing blockages and those that had returned after previous treatment.

However, you could not participate if you were pregnant, breastfeeding, or planning a pregnancy. People with a severe medical condition that meant they might not live for another year, or those with certain problems in their blood vessels (like an aneurysm or tear), were also excluded. If you had an allergy to the materials in the stent, had a problem with kidney function, or were already taking part in another study for a new treatment, you couldn't join this one.

If you took part in this study, you would have undergone a procedure where the Dynetic-35 stent was placed in your narrowed iliac artery. This is a common procedure usually done by inserting a thin tube (catheter) into a blood vessel in your groin or arm and guiding it to the affected area. After the procedure, you would have had regular check-ups with the study team. These check-ups would usually involve doctor visits and possibly some scans or tests to see how well the stent was working and how you were feeling. The study followed participants for a long time, up to five years, to get a full picture of the stent's safety and effectiveness over time.